The pharmaceutical industry is a key partner in Europe’s fight against disease, developing new treatments and cures for patients across Europe. It is imperative that Europe remains a competitive destination for medical research and development by maintaining, sustaining and developing a predictable, robust regulatory and innovation-supportive incentives environment.

Transport emissions in the EU’s Member States keep rising. If
the EU is serious about achieving the Paris Agreement’s 1.5°C objective,
European transport policies must radically change. The report, published today
by the Unify partners, assesses transport policies of the EU.